tradingkey.logo

Zai Lab Ltd

ZLAB
18.000USD
+1.020+6.01%
종가 02/06, 16:00ET시세는 15분 지연됩니다
1.99B시가총액
손실P/E TTM

Zai Lab Ltd

18.000
+1.020+6.01%

자세한 내용은 Zai Lab Ltd 회사

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Zai Lab Ltd 정보

종목 코드 ZLAB
회사 이름Zai Lab Ltd
상장일Sep 28, 2020
CEODu (Ying)
직원 수1869
유형Depository Receipt
회계 연도 종료Sep 28
주소Building B, 899 Halei Road, Pudong
도시SHANGHAI
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가China
우편 번호201203
전화862161632588
웹사이트https://www.zailaboratory.com/
종목 코드 ZLAB
상장일Sep 28, 2020
CEODu (Ying)

Zai Lab Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10831.00%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+10000.00%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-2983.00%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
17.44K
-240.00%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10831.00%
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
86.60K
+10000.00%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-2983.00%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
17.44K
-240.00%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
사업별USD
이름
수익
비율
ZEJULA
42.43M
36.78%
VYVGART
27.73M
24.03%
NUZYRA
15.43M
13.38%
Optune
12.66M
10.97%
QINLOCK
8.90M
7.72%
기타
8.21M
7.12%
지역별USD
이름
수익
비율
China (Mainland)
116.09M
0.00%
사업별
지역별
사업별USD
이름
수익
비율
ZEJULA
42.43M
36.78%
VYVGART
27.73M
24.03%
NUZYRA
15.43M
13.38%
Optune
12.66M
10.97%
QINLOCK
8.90M
7.72%
기타
8.21M
7.12%

주식 보유 통계

마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Capital World Investors
5.39%
Fidelity Management & Research Company LLC
3.79%
Norges Bank Investment Management (NBIM)
3.41%
ClearBridge Investments, LLC
3.12%
RTW Investments L.P.
2.03%
기타
82.26%
주주
주주
비율
Capital World Investors
5.39%
Fidelity Management & Research Company LLC
3.79%
Norges Bank Investment Management (NBIM)
3.41%
ClearBridge Investments, LLC
3.12%
RTW Investments L.P.
2.03%
기타
82.26%
주주 유형
주주
비율
Investment Advisor
15.68%
Investment Advisor/Hedge Fund
12.47%
Sovereign Wealth Fund
3.58%
Hedge Fund
2.94%
Individual Investor
1.78%
Private Equity
1.44%
Venture Capital
1.12%
Research Firm
0.61%
Pension Fund
0.02%
기타
60.34%

기관 주식 보유

마지막 업데이트: Wed, Jan 21
마지막 업데이트: Wed, Jan 21
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
280
37.42M
42.38%
--
2025Q4
369
40.92M
36.54%
-16.68M
2025Q3
372
46.61M
41.70%
-15.37M
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
2023Q4
497
46.31M
46.92%
-16.57M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Capital World Investors
6.08M
5.43%
+41.48K
+0.69%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.28M
3.82%
-610.67K
-12.50%
Sep 30, 2025
ClearBridge Investments, LLC
3.52M
3.14%
-492.62K
-12.28%
Sep 30, 2025
RTW Investments L.P.
2.29M
2.05%
-3.25M
-58.62%
Sep 30, 2025
Janus Henderson Investors
2.05M
1.83%
-148.32K
-6.75%
Sep 30, 2025
Wellington Management Company, LLP
1.72M
1.53%
+341.49K
+24.80%
Sep 30, 2025
Frazier Life Sciences Management, L.P.
1.63M
1.45%
+319.18K
+24.40%
Sep 30, 2025
Baron Capital Management, Inc.
1.37M
1.22%
-216.57K
-13.64%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Tema Oncology ETF
1.67%
ALPS Medical Breakthroughs ETF
1.19%
Virtus LifeSci Biotech Products ETF
0.97%
Invesco Golden Dragon China ETF
0.58%
National Security Emerging Markets Index ETF
0.39%
iShares Biotechnology ETF
0.18%
Capital Group New Geography Equity ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
ActivePassive International Equity ETF
0.03%
더 보기
Tema Oncology ETF
비율1.67%
ALPS Medical Breakthroughs ETF
비율1.19%
Virtus LifeSci Biotech Products ETF
비율0.97%
Invesco Golden Dragon China ETF
비율0.58%
National Security Emerging Markets Index ETF
비율0.39%
iShares Biotechnology ETF
비율0.18%
Capital Group New Geography Equity ETF
비율0.15%
ProShares Ultra Nasdaq Biotechnology
비율0.12%
Invesco Nasdaq Biotechnology ETF
비율0.12%
ActivePassive International Equity ETF
비율0.03%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI